Clinical MedicinePub Date : 2025-03-04DOI: 10.1016/j.clinme.2025.100300
Mohamed Hussein, Jason Dunn, Farhana Sultanah-Miah, Sami Hoque, Ahmed Albusoda, Esra Asilmaz, Laura Marelli, Regina Raymond, Mohsen Eldragini, Michael Grimes, Shraddha Gulati, Juriese Saramosing, Mayur Kumar, Eleanor Knights, Vinay Sehgal, Paul Maxwell, Arun Rajendran, Shamima Padaruth, Sophie Stevens, Sergio Coda, Edward Despott, Saswata Banerjee
{"title":"Transforming Trans-nasal Endoscopy Services: A multicentre service evaluation pilot project.","authors":"Mohamed Hussein, Jason Dunn, Farhana Sultanah-Miah, Sami Hoque, Ahmed Albusoda, Esra Asilmaz, Laura Marelli, Regina Raymond, Mohsen Eldragini, Michael Grimes, Shraddha Gulati, Juriese Saramosing, Mayur Kumar, Eleanor Knights, Vinay Sehgal, Paul Maxwell, Arun Rajendran, Shamima Padaruth, Sophie Stevens, Sergio Coda, Edward Despott, Saswata Banerjee","doi":"10.1016/j.clinme.2025.100300","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100300","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the impact of pilot Transnasal endoscopy (TNE) services on workforce efficiency, allocated procedure times and patient tolerance of procedures. The aim was to also understand the challenges of setting up a TNE service.</p><p><strong>Methods: </strong>Six-month data was collected from ten sites. Data captured included productivity, performance, workforce numbers, facilities and quality metrics. A patient survey was done to capture patient's experience. An eight likert-style and open question survey was designed and used. Pilot sites were visited using a semi-structured interview process.</p><p><strong>Results: </strong>30% of the pilot sites carried out the TNE service outside of the endoscopy unit. There is an overall 25% improvement in workforce efficiency with TNE. Of those patients that had both a TNE and OGD 78% of patients reported that having the TNE procedure was a better experience. All sites reported that they will continue providing TNE beyond the pilot period. Sites carrying out TNE reported a high satisfaction with the services. Overall satisfaction with the quality of TNE imaging was very high.</p><p><strong>Conclusions: </strong>This multicentre pilot project shows evidence that the integration of TNE services has a positive impact in increasing capacity and patient satisfaction. This should set the scene for scaling this up on a wider capacity. TNE services particularly with an introduction into outpatients will improve service capacity in endoscopy, patients will tolerate the procedures more, national two week wait, and Faster Diagnostic Standard targets will improve, and it is potentially more cost efficient overall.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100300"},"PeriodicalIF":3.6,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143572408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-27DOI: 10.1016/j.clinme.2025.100299
Rui Yang, Tao Huang, Renqi Yao, Di Wang, Yang Hu, Longbing Ren, Shaojie Li, Yali Zhao, Zhijun Dai
{"title":"Risk Factors and An Interpretability Tool of In-hospital Mortality in Critically Ill Patients with Acute Myocardial Infarction.","authors":"Rui Yang, Tao Huang, Renqi Yao, Di Wang, Yang Hu, Longbing Ren, Shaojie Li, Yali Zhao, Zhijun Dai","doi":"10.1016/j.clinme.2025.100299","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100299","url":null,"abstract":"<p><strong>Purpose: </strong>We aim to develop and validate an interpretable machine-learning model that can provide critical information for the clinical treatment of critically ill patients with acute myocardial infarction (AMI).</p><p><strong>Methods: </strong>All data was extracted from the multi-centre database (training and internal validation cohorts: MIMIC-III/-IV, external validation cohort: eICU). After comparing different machine-learning models and several unbalanced data processing methods, the model with the best performance was selected. Lasso regression was used to build a compact model. Seven evaluation methods, PR, and ROC curves were used to assess the model. The SHapley Additive exPlanations (SHAP) values were calculated to evaluate the feature's importance. The SHAP plots were adopted to explain and interpret the results. A web-based tool was developed to help application.</p><p><strong>Results: </strong>A total of 12,170 critically ill patients with AMI were included. The balance random forest (BRF) model had the best performance in predicting in-hospital mortality. The compact model did not differ from the full variable model in performance (AUC: 0.891 vs 0.885, P = 0.06). The external validation results also demonstrated the stability of the model (AUC: 0.784). All SHAP plots have shown the contribution ranking of all variables in the model, the relationship trend between variables and outcomes, and the interaction mode between variables. A web-based tool is constructed that can provide individualized risk stratification probabilities (https://github.com/huangtao36/BRF-web-tool) .</p><p><strong>Conclusion: </strong>We built the BRF model and the web-based tool by the model algorithm. The model effect has been verified externally. The tool can help clinical decision-making.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100299"},"PeriodicalIF":3.6,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143536893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-22DOI: 10.1016/j.clinme.2025.100298
Maria S Varughese, Fidelma O'Mahony, Lakshminarayanan Varadhan
{"title":"GLP-1 receptor agonist therapy and pregnancy: Evolving and emerging evidence.","authors":"Maria S Varughese, Fidelma O'Mahony, Lakshminarayanan Varadhan","doi":"10.1016/j.clinme.2025.100298","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100298","url":null,"abstract":"<p><p>The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in young adults, posing significant risks around pregnancy. Obesity also impacts on fertility and the co-existence of polycystic ovarian syndrome increases the prevalence of cardiovascular metabolic risk factors. There has been a renewed interest in glucagon-like peptide-1 receptor agonists (GLP-1RA) in this context, due to their multi-dimensional impact on the reproductive axis, as well as their ability to simultaneously target weight loss and glycaemic control. There is however limited availability of safety data with respect to the newer non-insulin-based diabetes medications from the perspective of fetal development. As GLP-1RA are not licensed for use in pregnancy, with the increasing chances of incidental exposure from pre-conception use for obesity and T2DM, it is imperative that pre-conception counselling should be an integral part of consultation prior to the initiation of these drugs.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100298"},"PeriodicalIF":3.6,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143491007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-22DOI: 10.1016/j.clinme.2025.100295
Grazia Caci, Arielle Selya, Giusy Rita Maria La Rosa, Lucia Spicuzza, Jaymin B Morjaria, Giulio Geraci, Riccardo Polosa
{"title":"RESPIRATORY EFFECTS OF ELECTRONIC CIGARETTE USE IN INDIVIDUALS WHO NEVER SMOKED: A SYSTEMATIC REVIEW.","authors":"Grazia Caci, Arielle Selya, Giusy Rita Maria La Rosa, Lucia Spicuzza, Jaymin B Morjaria, Giulio Geraci, Riccardo Polosa","doi":"10.1016/j.clinme.2025.100295","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100295","url":null,"abstract":"<p><p>Current evidence on whether electronic cigarettes (ECs) pose respiratory risks is unclear, due to confounding by cigarette smoking; evidence among never-smoking individuals is needed. Following a narrative review and critical appraisal, a systematic review assessed possible respiratory outcomes prospectively associated with EC use among individuals who never smoked. Bias risk was evaluated using Joanna Briggs Institute tool. Ten eligible studies examined outcomes of self-reported respiratory diagnosis, symptoms, and lung function. Eight examined adults and three examined youth (with overlap). Overall, seven studies showed no significant association between respiratory outcomes and EC use among never-smoking individuals (P>.05). Evidence for coughing and wheezing symptoms varied by model specification. Overall, EC use by never-smoking individuals is not associated with risk of severe respiratory outcomes, but may be associated with mild coughing/wheezing. Further research is needed using larger samples, long-term follow-ups (>5 years), and information on detailed patterns of EC use.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100295"},"PeriodicalIF":3.6,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143491015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-22DOI: 10.1016/j.clinme.2025.100297
Clare Macdonald, Elizabeth Dapre
{"title":"Perinatal care in primary care for cardiovascular risk reduction.","authors":"Clare Macdonald, Elizabeth Dapre","doi":"10.1016/j.clinme.2025.100297","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100297","url":null,"abstract":"<p><p>General Practitioners (GPs) and multidisciplinary members of the primary care team in the UK have, since the earliest days of the NHS, played a key role in the care of women throughout their perinatal journey, particularly postnatally. With cardiometabolic complications of pregnancy becoming increasingly common, and bringing an associated increased lifetime risk of adverse maternal and neonatal outcomes, GPs and the wider primary care team play a crucial role in risk reduction and management. Managing healthcare effectively to reduce adverse maternal and neonatal outcomes and health inequalities requires a system-wide change in approach where women's pre-conception to postnatal health is optimised. GPs' role in postnatal care, and other opportunistic moments in primary care for health promotion and risk management, is a key part of the solution.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100297"},"PeriodicalIF":3.6,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143491013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-20DOI: 10.1016/j.clinme.2025.100296
Shirley Sze, Chokanan Thaitirarot, Sunanthiny Krishnan, Daniel Chan, Will Nicolson, Iain Squire, Louise Clayton, Ian Loke
{"title":"Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction - a real-world experience.","authors":"Shirley Sze, Chokanan Thaitirarot, Sunanthiny Krishnan, Daniel Chan, Will Nicolson, Iain Squire, Louise Clayton, Ian Loke","doi":"10.1016/j.clinme.2025.100296","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100296","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the feasibility, safety and efficacy of early and rapid initiation of quadruple therapy (4 drugs in 4 weeks - \"4×4 approach\") for heart failure with reduced ejection fraction (HFrEF) patients in a real-world clinical setting.</p><p><strong>Design: </strong>Prospective service evaluation study SETTING: Secondary care PARTICIPANTS: Consecutive patients with de-novo HFrEF between March and August 2021 INTERVENTION: \"4×4 approach\" - individualised initiation and up-titration of 4 pillars HFrEF therapy by heart failure specialist MAIN OUTCOME: Proportion of patients initiated on 4 pillars of HFrEF therapy within 4 weeks RESULTS: Of 100 patients approached, 19 patients were not suitable for rapid up-titration pathway due to severe frailty and significant comorbidities. Eighty-one patients were enrolled [61% male, median age=73 years, median N-terminal Pro-Brain Natriuretic Peptide (NT-proBNP) = 3764 ng/L]. 39 patients (48%) achieved 4×4. Of the 42 patients who did not, 26 (62%), 9 (21%), and 7 (17%) patients were on 3 drugs, 2 drugs, and 1 drug, respectively. Thirty-three patients had one or more contraindication at the outset; most commonly renal impairment (28%), bradycardia (18%) and hyperkalaemia (15%). Five patients experienced significant side effects during medication up-titration, most commonly symptomatic hypotension. During median follow up of 554 days, 32 (40%) patients experienced the combined outcome (all-cause hospitalisation/ death). Patients who did not achieve 4×4 had an increased risk of the combined outcome [HR 2.25 (1.09-4.68), p=0.029] compared to those who achieved 4×4.</p><p><strong>Conclusion: </strong>Early and rapid initiation of 4 pillars HFrEF therapy is clinically feasible and safe when implemented in selected patients and is associated with improved clinical outcomes.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100296"},"PeriodicalIF":3.6,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143476358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-13DOI: 10.1016/j.clinme.2025.100294
De Yee Gan, Chin Meng Lee, Shakirin Pairan, Raja Ahmad Reza Raja Lope Ahmad, Hamdi Najman Achok
{"title":"A Case of Ascending Paralysis in Pregnancy: Thiamine Deficiency Mimicking Guillain-Barré Syndrome.","authors":"De Yee Gan, Chin Meng Lee, Shakirin Pairan, Raja Ahmad Reza Raja Lope Ahmad, Hamdi Najman Achok","doi":"10.1016/j.clinme.2025.100294","DOIUrl":"https://doi.org/10.1016/j.clinme.2025.100294","url":null,"abstract":"<p><p>Thiamine (Vitamin B1) deficiency may present with diverse symptoms and is often triggered by chronic alcoholism, severe malnutrition, or hyperemesis gravidarum. While typically diagnosed clinically, atypical presentations may delay recognition and treatment. We report a 26-year-old pregnant woman in her second trimester with prolonged nausea and vomiting since early pregnancy. She developed ascending lower limb paralysis, dysarthria, horizontal nystagmus, and lagophthalmos. Initially managed as hypokalaemia periodic paralysis with thyrotoxicosis and later Guillain-Barré Syndrome (GBS), her symptoms worsened despite treatment. Subsequent MRI brain imaging revealed findings indicative of Wernicke encephalopathy, prompting high-dose thiamine therapy. This resulted in significant neurological improvement. This case underscores the importance of considering thiamine deficiency in atypical neurological presentations, particularly in pregnancy. Early recognition and prompt treatment can mitigate irreversible neurological damage, emphasizing the necessity of maintaining a high index of suspicion in clinical practice.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100294"},"PeriodicalIF":3.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143424848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-11DOI: 10.1016/j.clinme.2025.100293
Jinyoung Shin, Sang-Hyun Park, Jae Hoon Cho, Tae-Eun Kim
{"title":"Body fat changes and risk of new onset of hypertension and hyperlipidaemia among Korean adults: A longitudinal study.","authors":"Jinyoung Shin, Sang-Hyun Park, Jae Hoon Cho, Tae-Eun Kim","doi":"10.1016/j.clinme.2025.100293","DOIUrl":"10.1016/j.clinme.2025.100293","url":null,"abstract":"<p><strong>Background: </strong>This study examined the association between changes in body fat, body mass index (BMI), and the risk of newly developed hypertension and hyperlipidaemia in the general population.</p><p><strong>Methods: </strong>This longitudinal study included 17,598 individuals without prior hypertension and hyperlipidaemia who underwent at least three health examinations between January 2015 and December 2022. Body fat was classified as decreased (≥ 5%), stable (within 5%), and increased (≥ 5%) using bioelectrical impedance analysis. BMIs were categorised as healthy weight/underweight (BMI < 23), overweight (23 ≤ BMI < 25), and obesity (BMI ≥ 25). Hypertension and hyperlipidaemia were identified through self-reported medication use or clinical measurements.</p><p><strong>Results: </strong>Increases in BMI or body fat were associated with higher incidence rates of hypertension and hyperlipidaemia. Decreased body fat was associated with a lower risk of hypertension in the overweight (odds ratio: 0.638, 95% confidence interval: 0.464-0.876) and obese groups (0.724, 0.577-0.909). Individuals with healthy weight/underweight with increased body fat had a higher incidence of hyperlipidaemia than individuals with overweight with decreased body fat (87.2 vs 66.4 per 1,000 people). Compared to the stable body fat group, increased body fat raised the risk of hyperlipidaemia (healthy weight/underweight: 1.522, 1.248-1.855; overweight: 1.278, 1.032-1.583; and obesity: 1.214, 1.028-1.433). Individuals living with overweight with decreased body fat demonstrated a lower risk of hyperlipidaemia (0.546, 0.400-0.747).</p><p><strong>Conclusions: </strong>Increased body fat was associated with a higher risk of hyperlipidaemia, even within the same BMI category. Decreasing body fat, particularly in individuals living with overweight, is associated with a lower risk of hypertension and hyperlipidaemia.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100293"},"PeriodicalIF":3.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143413624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical MedicinePub Date : 2025-02-06DOI: 10.1016/j.clinme.2025.100292
Baldev Singh, Nisha Kumari-Dewat, Adam Ryder, Vijay Klaire, Hannah Jennens, Kamran Ahmed, Mona Sidhu, Ananth Viswanath, Emma Parry
{"title":"Developing an electronic surprise question to predict end-of-life prognosis in a prospective cohort study of acute hospital admissions.","authors":"Baldev Singh, Nisha Kumari-Dewat, Adam Ryder, Vijay Klaire, Hannah Jennens, Kamran Ahmed, Mona Sidhu, Ananth Viswanath, Emma Parry","doi":"10.1016/j.clinme.2025.100292","DOIUrl":"10.1016/j.clinme.2025.100292","url":null,"abstract":"<p><strong>Objective: </strong>Determining the accuracy of a method calculating the Gold Standards Framework Surprise Question (GSFSQ) equivalent end-of-life prognosis amongst hospital inpatients.</p><p><strong>Design: </strong>A prospective cohort study with regression calculated 1-year mortality probability. Probability cut points triaged unknown prognosis into the GSFSQ equivalent 'Yes' or 'No' survival categories (> or < 1-year respectively), with subsidiary classification of 'No'. Prediction was tested against prospective mortality.</p><p><strong>Setting: </strong>An acute NHS hospital.</p><p><strong>Participants: </strong>18,838 acute medical admissions.</p><p><strong>Interventions: </strong>Allocation of mortality probability by binary logistic regression model (X<sup>2</sup>=6,650.2, p<0.001, r<sup>2</sup> = 0.43) and stepwise algorithmic risk-stratification.</p><p><strong>Main outcome measure: </strong>Prospective mortality at 1-year.</p><p><strong>Results: </strong>End-of-life prognosis was unknown in 67.9%. The algorithm's prognosis allocation (100% vs baseline 32.1%) yielded cohorts of GSFSQ-Yes 15,264 (81%), GSFSQ-No Green 1,771 (9.4%) and GSFSQ-No Amber or Red 1,803 (9.6%). There were 5,043 (26.8%) deaths at 1-year. In Cox's survival, model allocated cohorts were discrete for mortality (GSFSQ-Yes 16.4% v GSFSQ-No 71.0% (p<0.001). For the GSFSQ-No classification, the mortality odds ratio was 12.4 (11.4-13.5) (p<0.001) vs GSFSQ-Yes (c-statistic 0.72 (0.70-0.73), p<0.001; accuracy, positive and negative predictive values 81.2%, 83.6%, 83.6%, respectively). Had the tool been utilised at the time of admission, the potential to reduce possibly avoidable subsequent hospital admissions, death-in-hospital and bed days was significant (p<0.001).</p><p><strong>Conclusion: </strong>This study is unique in methodology with prospectively evidenced outcomes. The model algorithm allocated GSFSQ equivalent EOL prognosis universally to a cohort of acutely admitted patients with statistical accuracy validated against prospective mortality outcomes.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100292"},"PeriodicalIF":3.6,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143373999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bilateral adrenal infarction and secondary haemorrhage in pregnancy: implications of factor V Leiden heterozygosity. A review of the literature and a case report.","authors":"Wiaam Elradi, Samreen Innayat, Ahmed Hanafy, Sharifah Naseem, Abuzar Awadelkareem, Deepika Meneni","doi":"10.1016/j.clinme.2025.100288","DOIUrl":"10.1016/j.clinme.2025.100288","url":null,"abstract":"<p><p>Adrenal haemorrhage in pregnancy is rare but can lead to significant maternal and fetal morbidity if unrecognised. We present the case of a 25-year-old woman in her second pregnancy, who was admitted at 34 + 4 weeks of gestation with severe abdominal pain. Despite initial unremarkable assessments, further imaging revealed a left adrenal haemorrhage, with evidence of prior right adrenal infarction, resulting in primary adrenal insufficiency. Haematological investigations later confirmed heterozygous factor V Leiden as a likely contributing factor. This report underscores the diagnostic challenges of adrenal pathology in pregnancy, where symptoms may overlap with more common conditions. Immediate management with hydrocortisone therapy, supported by a multidisciplinary team (MDT), was employed, with a successful outcome for both mother and child following delivery by caesarean section.</p>","PeriodicalId":10492,"journal":{"name":"Clinical Medicine","volume":" ","pages":"100288"},"PeriodicalIF":3.6,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11847723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143045760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}